Oxford Finance and its healthcare leveraged lending group closed a strong first half of 2023, providing approximately $1 billion of commitments across 13 new platform investments and supporting multiple follow-on investments by portfolio companies.
Amino Health closed $80 million in both equity and debt financing led by Transformation Capital and Oxford Finance, respectively. In the face of declining digital health investment, this funding enables the company to scale its technology and continue its growth trajectory.
Oxford Finance and its healthcare real estate group closed a company record level of originations in 2022, with Oxford providing more than $867 million of capital commitments. The group closed a total of 14 transactions, with credit facilities ranging from $9 million to over $124 million.
Oxford Finance, a specialty finance firm focused on healthcare services and life sciences companies worldwide, closed a $115 million senior credit facility to Pearl Street Dental Partners, a dental platform owned by SkyKnight Capital, dentists and management.
ALX Oncology, a clinical-stage immuno-oncology company, entered into a loan facility agreement with Oxford Finance and Silicon Valley Bank for up to $100 million of non-dilutive financing.
Oxford Finance, a specialty finance firm providing senior debt to healthcare services and life sciences companies worldwide, closed a $124.75 million senior credit facility for the acquisition of four Autumn Lake Healthcare skilled nursing facilities located in Maryland containing 520 licensed beds.
Verona Pharma entered into a debt financing facility providing the company with access to up to $150 million from Oxford Finance. The $150 million debt facility replaces the existing $30 million facility with Silicon Valley Bank.
Greenbrook TMS closed its acquisition of Check Five, a Delaware limited liability company. In addition, Greenbrook entered into a credit agreement for a $75 million secured credit facility with Madryn Asset Management and its affiliated entities.
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy for all stages of cancer, closed a $125 million debt facility with Oxford Financial, of which $55 million is available immediately to repay the company’s existing $50 million of debt.
Oxford Finance closed a $30 million senior secured term loan with Selux Diagnostic, a Boston-based medical device company focused on personalized diagnostics to combat superbug infections and fight antibiotic resistance.